新娛科控股(06933.HK):預計中期溢利下降70%
格隆匯6月30日丨新娛科控股(06933.HK)發佈公吿,集團預期相比上年同期集團的約人民幣2040萬元期間溢利,集團截至2021年6月30止六個月的溢利將下降約70%。
公吿稱,該期間溢利減少主因來自發行自主開發遊戲的收益大幅度減少,該減少主要是由於目前運營的自主開發遊戲,其貢獻較高利潤率,已達其各自生命週期的較後階段,所以該等遊戲的每月付費用户(“MPU”)及付費用户每月平均收入(“ARPPU”)均下降,以及集團新制作的自主開發遊戲由於尚待中國國家新聞出版總署的預審程序,因此無法於該期間內推出。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.